A Study of INCB050465 in Subjects With Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204)
Clinical trial NCT03144674 · COMPLETED
Trial details
- NCT number
- NCT03144674
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-18
- Primary completion
- 2021-01-15
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.